List view / Grid view

Johnson & Johnson



Launch of Dementia Discovery Fund to deliver new dementia treatments by 2025

21 October 2015 | By Kate Douetil

This innovative new global investment fund has gained support from a wide variety of investors, including the UK Government’s Department of Health (DoH), Alzheimer’s Research UK and world-leading major pharmaceutical companies Biogen, GlaxoSmithKline, Johnson & Johnson, Lilly, Pfizer and Takeda...